Bli medlem
Bli medlem

Du är här


Moberg Pharma: Redeye: Moberg Pharma - Realizing value

By reshaping itself through the sale of the OTC business and its new
partnership with Bayer, Moberg Pharma has confirmed management's
strong commitment to creating and realizing shareholder value. We
raise our Management rating and feel increased conviction in the
company as a late-stage clinical development play.

Read more and download the Research Update:

Start following companies at Redeye to receive the latest equity
research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment


Författare Cision

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.